Skip to content

EBITDA at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-$12.93M+88.9%
Embecta Corp. logo
Embecta Corp.EMBC
$45.2M-37.1%
Owlet logo
OwletOWLT
-$5.31M-108%
Abbott logo
AbbottABT
DexCom logo
DexComDXCM
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$11.7M+87.2%
Gross profit$6.9M+361%
Operating income-$31.8M-136%
Net income-$32.3M-127%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$29.6M-24.7%
Total debt$43.1M+5.0%
Total equity$34.3M-2.4%
Total assets$102.9M+17.9%

Cash flow

See full
Operating cash flow-$32.0M-99.2%
CapEx$111.0K-74.4%
Free cash flow-$32.1M-94.6%

Valuation

See full
Market cap$296.51M-21.4%
Enterprise value$310.04M-19.9%
P/S7.3×-7.5×

Profitability

See full
Gross margin52.1%+44.9pp
Operating margin-213%-46.7pp
Net margin-214.1%-51.2pp
FCF margin-186.4%-37.0pp

Returns & leverage

See full
Return on equity-250.7%-19.0pp
Debt / equity1.3×+0.1×
Current ratio3.5×-3.4×

Where this comes from

Calculated from Senseonics Holdings, Inc. ’s reported figures.

$31.8Mebit+
$545.0KDepreciation Depletion & Amortization
=-$31.3M

The official record: Senseonics Holdings, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Senseonics Holdings, Inc. 's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Senseonics Holdings, Inc. 's EBITDA?
Senseonics Holdings, Inc. (SENS) reported EBITDA of -$31.3M in Q1 2026.
How has Senseonics Holdings, Inc. 's EBITDA changed year-over-year?
Senseonics Holdings, Inc. 's EBITDA decreased by 138.9% year-over-year, from -$13.1M to -$31.3M.
What is the long-term trend for Senseonics Holdings, Inc. 's EBITDA?
Over 4 years (2021 to 2025), Senseonics Holdings, Inc. 's EBITDA has grown at a 4.5% compound annual growth rate (CAGR), from -$55.94M to -$66.83M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.